nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ABCC1—Glyburide—gestational diabetes	0.414	0.44	CbGbCtD
Vemurafenib—ABCG2—Glyburide—gestational diabetes	0.277	0.294	CbGbCtD
Vemurafenib—ALB—Glyburide—gestational diabetes	0.191	0.203	CbGbCtD
Vemurafenib—CYP3A4—Glyburide—gestational diabetes	0.0599	0.0635	CbGbCtD
Vemurafenib—RAF1—Nongenotropic Androgen signaling—SHBG—gestational diabetes	0.00303	0.0905	CbGpPWpGaD
Vemurafenib—RAF1—islet of Langerhans—gestational diabetes	0.0025	0.113	CbGeAlD
Vemurafenib—BRAF—uterus—gestational diabetes	0.00245	0.111	CbGeAlD
Vemurafenib—RAF1—embryo—gestational diabetes	0.00242	0.11	CbGeAlD
Vemurafenib—BRAF—adipose tissue—gestational diabetes	0.0024	0.109	CbGeAlD
Vemurafenib—RAF1—Signaling by Leptin—LEPR—gestational diabetes	0.00232	0.0692	CbGpPWpGaD
Vemurafenib—BRAF—vagina—gestational diabetes	0.00199	0.0903	CbGeAlD
Vemurafenib—RAF1—uterus—gestational diabetes	0.00163	0.074	CbGeAlD
Vemurafenib—RAF1—adipose tissue—gestational diabetes	0.0016	0.0724	CbGeAlD
Vemurafenib—RAF1—vagina—gestational diabetes	0.00133	0.0602	CbGeAlD
Vemurafenib—RAF1—head—gestational diabetes	0.00123	0.0556	CbGeAlD
Vemurafenib—RAF1—FSH signaling pathway—CYP19A1—gestational diabetes	0.00113	0.0337	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—LEPR—gestational diabetes	0.000994	0.0297	CbGpPWpGaD
Vemurafenib—RAF1—Nongenotropic Androgen signaling—AR—gestational diabetes	0.000984	0.0294	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000826	0.0247	CbGpPWpGaD
Vemurafenib—ABCC1—uterus—gestational diabetes	0.000816	0.037	CbGeAlD
Vemurafenib—RAF1—Signaling by Leptin—LEP—gestational diabetes	0.000815	0.0243	CbGpPWpGaD
Vemurafenib—ABCC1—adipose tissue—gestational diabetes	0.000798	0.0362	CbGeAlD
Vemurafenib—ABCG2—uterus—gestational diabetes	0.000676	0.0306	CbGeAlD
Vemurafenib—ABCC1—vagina—gestational diabetes	0.000664	0.0301	CbGeAlD
Vemurafenib—ABCG2—adipose tissue—gestational diabetes	0.000661	0.0299	CbGeAlD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000659	0.0197	CbGpPWpGaD
Vemurafenib—BRAF—Negative regulation of FGFR signaling—FGF2—gestational diabetes	0.000634	0.0189	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—GLS2—gestational diabetes	0.000633	0.0189	CbGpPWpGaD
Vemurafenib—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000604	0.018	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000572	0.0171	CbGpPWpGaD
Vemurafenib—ALB—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.000563	0.0168	CbGpPWpGaD
Vemurafenib—ABCG2—vagina—gestational diabetes	0.000549	0.0249	CbGeAlD
Vemurafenib—BRAF—MAPK Signaling Pathway—GCK—gestational diabetes	0.000517	0.0154	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000475	0.0142	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GLS2—gestational diabetes	0.000438	0.0131	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000412	0.0123	CbGpPWpGaD
Vemurafenib—RAF1—FRS2-mediated cascade—FGF2—gestational diabetes	0.000406	0.0121	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000401	0.012	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—GCK—gestational diabetes	0.000358	0.0107	CbGpPWpGaD
Vemurafenib—RAF1—Leptin signaling pathway—LEP—gestational diabetes	0.000349	0.0104	CbGpPWpGaD
Vemurafenib—CYP2D6—head—gestational diabetes	0.000348	0.0158	CbGeAlD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—FGF2—gestational diabetes	0.00034	0.0101	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000337	0.0101	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000328	0.00979	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000278	0.00829	CbGpPWpGaD
Vemurafenib—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000278	0.00829	CbGpPWpGaD
Vemurafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000265	0.00791	CbGpPWpGaD
Vemurafenib—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000262	0.0078	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000258	0.00771	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000257	0.00766	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000242	0.00723	CbGpPWpGaD
Vemurafenib—RAF1—IRS-mediated signalling—FGF2—gestational diabetes	0.00024	0.00716	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000239	0.00712	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events—FGF2—gestational diabetes	0.000233	0.00696	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events triggered by IGF1R—FGF2—gestational diabetes	0.000231	0.0069	CbGpPWpGaD
Vemurafenib—RAF1—Ceramide signaling pathway—TNF—gestational diabetes	0.000231	0.00688	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.00023	0.00686	CbGpPWpGaD
Vemurafenib—RAF1—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.000225	0.00672	CbGpPWpGaD
Vemurafenib—RAF1—IGF1R signaling cascade—FGF2—gestational diabetes	0.000225	0.00672	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000225	0.0067	CbGpPWpGaD
Vemurafenib—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000222	0.00661	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000221	0.0066	CbGpPWpGaD
Vemurafenib—Vasculitis—Glyburide—gestational diabetes	0.000221	0.111	CcSEcCtD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000215	0.00641	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000214	0.0064	CbGpPWpGaD
Vemurafenib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000214	0.00639	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—FGF2—gestational diabetes	0.000207	0.00618	CbGpPWpGaD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000207	0.00617	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000193	0.00575	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000187	0.00558	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000182	0.00543	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—gestational diabetes	0.000179	0.00534	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000173	0.00517	CbGpPWpGaD
Vemurafenib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000171	0.0051	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000171	0.0051	CbGpPWpGaD
Vemurafenib—Arthritis—Glyburide—gestational diabetes	0.000161	0.0807	CcSEcCtD
Vemurafenib—RAF1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00016	0.00477	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000153	0.00457	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000153	0.00457	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—GCK—gestational diabetes	0.000151	0.00451	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—FGF2—gestational diabetes	0.000151	0.0045	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MBL2—gestational diabetes	0.000148	0.00443	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000147	0.0044	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—FGF2—gestational diabetes	0.000144	0.00429	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—FGF2—gestational diabetes	0.000143	0.00427	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—FGF2—gestational diabetes	0.000142	0.00425	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—FGF2—gestational diabetes	0.000142	0.00423	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00014	0.00419	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000137	0.00409	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000136	0.00405	CbGpPWpGaD
Vemurafenib—Eosinophilia—Glyburide—gestational diabetes	0.000134	0.0671	CcSEcCtD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000133	0.00398	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000133	0.00398	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—FGF2—gestational diabetes	0.000133	0.00398	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—FGF2—gestational diabetes	0.000132	0.00394	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—FGF2—gestational diabetes	0.000131	0.00392	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000131	0.00391	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—FGF2—gestational diabetes	0.00013	0.00389	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000128	0.00383	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000127	0.00379	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000126	0.00375	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GGCT—gestational diabetes	0.000125	0.00373	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—ADIPOQ—gestational diabetes	0.000124	0.00371	CbGpPWpGaD
Vemurafenib—Photosensitivity reaction—Glyburide—gestational diabetes	0.000123	0.0619	CcSEcCtD
Vemurafenib—BRAF—MAPK Signaling Pathway—TNF—gestational diabetes	0.000122	0.00365	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000118	0.00353	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000118	0.00353	CbGpPWpGaD
Vemurafenib—BRAF—Disease—RBP4—gestational diabetes	0.000116	0.00347	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000114	0.00341	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000113	0.00336	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000112	0.00334	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GGCT—gestational diabetes	0.00011	0.00328	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GLS2—gestational diabetes	0.000109	0.00326	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LEPR—gestational diabetes	0.000106	0.00315	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NAMPT—gestational diabetes	0.000104	0.00311	CbGpPWpGaD
Vemurafenib—BRAF—Disease—GCK—gestational diabetes	0.000104	0.00309	CbGpPWpGaD
Vemurafenib—Eye disorder—Glyburide—gestational diabetes	0.000101	0.0507	CcSEcCtD
Vemurafenib—RAF1—Signaling by GPCR—MTNR1B—gestational diabetes	9.79e-05	0.00292	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.78e-05	0.00292	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	9.67e-05	0.00288	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—gestational diabetes	9.62e-05	0.00287	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GLS2—gestational diabetes	9.62e-05	0.00287	CbGpPWpGaD
Vemurafenib—Alopecia—Glyburide—gestational diabetes	9.56e-05	0.048	CcSEcCtD
Vemurafenib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	9.54e-05	0.00285	CbGpPWpGaD
Vemurafenib—Erythema—Glyburide—gestational diabetes	9.42e-05	0.0473	CcSEcCtD
Vemurafenib—Malnutrition—Glyburide—gestational diabetes	9.42e-05	0.0473	CcSEcCtD
Vemurafenib—RAF1—Signaling by NGF—FGF2—gestational diabetes	9.09e-05	0.00271	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	8.99e-05	0.00268	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.99e-05	0.00268	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MBL2—gestational diabetes	8.64e-05	0.00258	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—gestational diabetes	8.47e-05	0.00253	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MTNR1B—gestational diabetes	8.36e-05	0.00249	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RBP4—gestational diabetes	8.14e-05	0.00243	CbGpPWpGaD
Vemurafenib—RAF1—Disease—RBP4—gestational diabetes	8.05e-05	0.0024	CbGpPWpGaD
Vemurafenib—Arthralgia—Glyburide—gestational diabetes	8.02e-05	0.0402	CcSEcCtD
Vemurafenib—Myalgia—Glyburide—gestational diabetes	8.02e-05	0.0402	CcSEcCtD
Vemurafenib—ABCC1—Disease—RBP4—gestational diabetes	7.98e-05	0.00238	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—LEP—gestational diabetes	7.72e-05	0.00231	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	7.65e-05	0.00228	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.64e-05	0.00228	CbGpPWpGaD
Vemurafenib—Nervous system disorder—Glyburide—gestational diabetes	7.54e-05	0.0378	CcSEcCtD
Vemurafenib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.46e-05	0.00223	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	7.36e-05	0.0022	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LEPR—gestational diabetes	7.31e-05	0.00218	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NAMPT—gestational diabetes	7.22e-05	0.00215	CbGpPWpGaD
Vemurafenib—Hypotension—Glyburide—gestational diabetes	7.18e-05	0.036	CcSEcCtD
Vemurafenib—RAF1—Disease—GCK—gestational diabetes	7.17e-05	0.00214	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NAMPT—gestational diabetes	7.15e-05	0.00213	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—GCK—gestational diabetes	7.11e-05	0.00212	CbGpPWpGaD
Vemurafenib—Musculoskeletal discomfort—Glyburide—gestational diabetes	7.01e-05	0.0351	CcSEcCtD
Vemurafenib—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	6.9e-05	0.00206	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GGCT—gestational diabetes	6.79e-05	0.00203	CbGpPWpGaD
Vemurafenib—Decreased appetite—Glyburide—gestational diabetes	6.68e-05	0.0335	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Glyburide—gestational diabetes	6.64e-05	0.0333	CcSEcCtD
Vemurafenib—ABCC1—Metabolism—NAMPT—gestational diabetes	5.99e-05	0.00179	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GCK—gestational diabetes	5.95e-05	0.00178	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GLS2—gestational diabetes	5.94e-05	0.00177	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—FGF2—gestational diabetes	5.87e-05	0.00175	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MTNR1B—gestational diabetes	5.78e-05	0.00173	CbGpPWpGaD
Vemurafenib—Hypersensitivity—Glyburide—gestational diabetes	5.67e-05	0.0284	CcSEcCtD
Vemurafenib—RAF1—Signaling Pathways—RBP4—gestational diabetes	5.63e-05	0.00168	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGCT—gestational diabetes	5.61e-05	0.00167	CbGpPWpGaD
Vemurafenib—Asthenia—Glyburide—gestational diabetes	5.52e-05	0.0277	CcSEcCtD
Vemurafenib—Pruritus—Glyburide—gestational diabetes	5.44e-05	0.0273	CcSEcCtD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.31e-05	0.00158	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NAMPT—gestational diabetes	5.27e-05	0.00157	CbGpPWpGaD
Vemurafenib—Diarrhoea—Glyburide—gestational diabetes	5.26e-05	0.0264	CcSEcCtD
Vemurafenib—ABCG2—Metabolism—GCK—gestational diabetes	5.24e-05	0.00156	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FGF2—gestational diabetes	5.18e-05	0.00155	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—FGF2—gestational diabetes	4.98e-05	0.00149	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GLS2—gestational diabetes	4.9e-05	0.00146	CbGpPWpGaD
Vemurafenib—Vomiting—Glyburide—gestational diabetes	4.89e-05	0.0245	CcSEcCtD
Vemurafenib—Rash—Glyburide—gestational diabetes	4.85e-05	0.0243	CcSEcCtD
Vemurafenib—Dermatitis—Glyburide—gestational diabetes	4.84e-05	0.0243	CcSEcCtD
Vemurafenib—Headache—Glyburide—gestational diabetes	4.82e-05	0.0242	CcSEcCtD
Vemurafenib—CYP1A2—Metabolism—GGCT—gestational diabetes	4.75e-05	0.00142	CbGpPWpGaD
Vemurafenib—Nausea—Glyburide—gestational diabetes	4.57e-05	0.0229	CcSEcCtD
Vemurafenib—ABCC1—Metabolism—CYP19A1—gestational diabetes	4.35e-05	0.0013	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GLS2—gestational diabetes	4.15e-05	0.00124	CbGpPWpGaD
Vemurafenib—BRAF—Disease—FGF2—gestational diabetes	4.03e-05	0.0012	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP19A1—gestational diabetes	3.83e-05	0.00114	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LEP—gestational diabetes	3.71e-05	0.00111	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.71e-05	0.00111	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGCT—gestational diabetes	3.67e-05	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—gestational diabetes	3.57e-05	0.00107	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NAMPT—gestational diabetes	3.25e-05	0.000971	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GCK—gestational diabetes	3.23e-05	0.000965	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.21e-05	0.000956	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FGF2—gestational diabetes	3.02e-05	0.000901	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGF2—gestational diabetes	2.82e-05	0.000842	CbGpPWpGaD
Vemurafenib—RAF1—Disease—FGF2—gestational diabetes	2.79e-05	0.000832	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—FGF2—gestational diabetes	2.76e-05	0.000824	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.69e-05	0.000802	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCK—gestational diabetes	2.67e-05	0.000796	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LEP—gestational diabetes	2.57e-05	0.000767	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP19A1—gestational diabetes	2.36e-05	0.000705	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.28e-05	0.000679	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCK—gestational diabetes	2.26e-05	0.000675	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.95e-05	0.000582	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF2—gestational diabetes	1.95e-05	0.000582	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.76e-05	0.000524	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCK—gestational diabetes	1.75e-05	0.000521	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.65e-05	0.000493	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.28e-05	0.000381	CbGpPWpGaD
